Developer docs
API playgroundTry for free, no card

Search company profiles

SpacePharma

Full company profile

uuid0008wsx

Namestring
SpacePharma
Legal namestring
SpacePharma
Websiteurl
space4p.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

SpacePharma is a Palo Alto-based, privately held space biotechnology company founded in 2012 that provides end-to-end microgravity research services and biomanufacturing solutions. The company develops and operates miniature laboratory platforms capable of conducting experiments in orbital microgravity conditions, enabling clients to test formulations, synthesize bioactive compounds, and develop ingredients that are difficult or impossible to produce under Earth gravity. Its core technology spans microgravity-based biomanufacturing, formulation testing, and the production of space-grown bioactive compounds with applications in radiation shielding and antioxidant formulations.

The company's commercial focus has recently pivoted toward the cosmetics and personal care industry, where it offers co-innovation and product testing services to skin care brands developing advanced formulations addressing environmental stressors such as radiation, pollution, and oxidative stress. SpacePharma serves this primary segment via a professional services / project-based revenue model, engaging clients through industry conferences (notably the IFSCC 2025 Congress) and strategic partnerships such as the September 2025 alliance with MEDES (Institute for Space Medicine) under the SpacePharma EU brand. The company is co-founded by Martin Aebi and Yossi Yamin (CEO), employs 51–100 people, has received funding from State of Mind Ventures (2015) and the EIC Accelerator (2024), and operates against a space biomanufacturing TAM projected by third-party research to grow from $1.8B in 2025 to $7.4B by 2034.

Revenue, pricing, named customers, and detailed financial metrics are not publicly disclosed, and the company's AI/ML capabilities are not evidenced in available source material.

Short descriptiontext

SpacePharma is a Palo Alto-based space biotechnology company founded in 2012 that provides microgravity research services and biomanufacturing platforms, primarily serving cosmetics and personal care clients developing advanced skin care formulations tested in orbital environments.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersPalo Alto, United States
HQ citystring
Palo Alto
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
microgravity research services, space biomanufacturing, cosmetic formulation testing, bioactive compound development, orbital laboratory services
Industry2 codes
1Analytical Development & QC Testing (Release/Stability/Potency)
CodeHLAGAGAFPrimaryYes
2Space Payloads & Instruments (Sensors, Comms, EO/IR)
CodeIMABACADPrimaryNo
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in Nanotechnology541713
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Space Biotechnology Research Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Co-innovation and Product Testing Services
TypeProfessional Services
Description

SpacePharma provides microgravity testing and co-innovation services to cosmetic and personal care companies, enabling product development partnerships

cosmeticsandtoiletries.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Cost components4 values
Technology or R&D, Personnel, Infrastructure, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

SpacePharma provides end-to-end microgravity services and solutions for research, enabling cosmetic, biotechnology, and pharmaceutical companies to test products and develop novel formulations in orbital microgravity environments. The company conducts space-based experiments yielding bioactive compounds, radiation-protective ingredients, and antioxidant formulations for skin care applications, and operates an orbital laboratory platform that supports co-innovation and product testing partnerships.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

SpacePharma is a space biotechnology company offering microgravity-based research and product testing services. Their core offering revolves around providing access to orbital environments where cosmetic, pharmaceutical, and biotech products can be tested and developed under microgravity conditions. The company participates in industry conferences (such as IFSCC 2025 Congress) to discuss co-innovation opportunities with partners in the cosmetics and personal care industries.

Product and service1 record
1Microgravity Research Services
CategoryMicrogravity Research and Testing Services
Description

Laboratory services leveraging microgravity environments for product testing and co-innovation, particularly in the cosmetics and biotechnology sectors. Enables researchers to conduct experiments in orbital conditions that yield insights for skin care formulations and bioactive compound development, targeting cosmetics and personal care companies as well as biotech and pharma research organizations.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-19
Description

MEDES (Institute for Space Medicine) and SpacePharma EU participated jointly in a round table discussion at IFSCC 2025 Congress exploring space research as a catalyst for cosmetic innovation. The partnership focuses on opportunities for co-innovation and product testing in microgravity environments, combining SpacePharma's microgravity expertise with MEDES' space medicine capabilities.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Operates a microgravity research services platform focused on biotech and life science experiments in low-Earth orbit, mirroring SpacePharma's end-to-end service model for biological and formulation research.

TypeBroad incumbent
Description

Established space infrastructure provider offering ISS payloads, biotech manufacturing facilities (e.g., BioFabrication Facility), and broader space services — competing in adjacent capabilities with significantly greater scale.

3Yuri
TypeDirect peer
Description

Germany-based microgravity research services company providing access to ISS and suborbital platforms for life sciences and biotech R&D — a comparable European-headquartered peer serving similar customer profiles.

TypeBroad incumbent
Description

Operates commercial ISS facilities and microgravity research services through the NanoRacks and Bishop Airlock franchises, serving as a larger-scale incumbent in commercial low-Earth-orbit R&D services.

TypeBroad incumbent
Description

Major European space hardware and services supplier offering payload structures, mechanisms, and experiment support — adjacent competitor with broader scope and substantial industrial scale.

TypeEmerging player
Description

Biotech company leveraging microgravity-based research for therapeutic antibody development; partial overlap with SpacePharma's space biotech platform but focused on oncology drug discovery rather than cosmetics.

TypeDirect peer
Description

Provides microgravity research and manufacturing services aboard the ISS for biotech and consumer applications, with overlapping capabilities in formulation testing and space-grown bioactives — a direct head-to-head competitor.

TypeBroad incumbent
Description

University of Colorado-affiliated research center operating microgravity life-science experiments and payloads on ISS for academic and commercial clients — overlapping capability base with deeper scientific pedigree but academic rather than commercial-first orientation.

TypeDirect peer
Description

UK-based microgravity research services company providing payload development and experiment services to biotech and pharma clients, comparable in size and European market positioning.

TypeDirect peer
Description

Operates the ICE-Cubes commercial service offering end-to-end access to the ISS for research payloads, with deep experience in biotech and pharma experiments analogous to SpacePharma's service scope.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SpacePharma

Space Biotechnology Research Servicesspace4p.com

SpacePharma is a Palo Alto-based space biotechnology company founded in 2012 that provides microgravity research services and biomanufacturing platforms, primarily serving cosmetics and personal care clients developing advanced skin care formulations tested in orbital environments.

What SpacePharma does

SpacePharma is a Palo Alto-based, privately held space biotechnology company founded in 2012 that provides end-to-end microgravity research services and biomanufacturing solutions. The company develops and operates miniature laboratory platforms capable of conducting experiments in orbital microgravity conditions, enabling clients to test formulations, synthesize bioactive compounds, and develop ingredients that are difficult or impossible to produce under Earth gravity. Its core technology spans microgravity-based biomanufacturing, formulation testing, and the production of space-grown bioactive compounds with applications in radiation shielding and antioxidant formulations.

The company's commercial focus has recently pivoted toward the cosmetics and personal care industry, where it offers co-innovation and product testing services to skin care brands developing advanced formulations addressing environmental stressors such as radiation, pollution, and oxidative stress. SpacePharma serves this primary segment via a professional services / project-based revenue model, engaging clients through industry conferences (notably the IFSCC 2025 Congress) and strategic partnerships such as the September 2025 alliance with MEDES (Institute for Space Medicine) under the SpacePharma EU brand. The company is co-founded by Martin Aebi and Yossi Yamin (CEO), employs 51–100 people, has received funding from State of Mind Ventures (2015) and the EIC Accelerator (2024), and operates against a space biomanufacturing TAM projected by third-party research to grow from $1.8B in 2025 to $7.4B by 2034.

Revenue, pricing, named customers, and detailed financial metrics are not publicly disclosed, and the company's AI/ML capabilities are not evidenced in available source material.

SpacePharma firmographics

Firmographics
Name
SpacePharma
Legal name
SpacePharma
Website
https://space4p.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
51–100 employees
Short description
SpacePharma is a Palo Alto-based space biotechnology company founded in 2012 that provides microgravity research services and biomanufacturing platforms, primarily serving cosmetics and personal care clients developing advanced skin care formulations tested in orbital environments.
Ownership category
akta.pro rank

SpacePharma industry classification

Industry
Product category
Space Biotechnology Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in Nanotechnology (541713)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro primary industry
Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF)
akta.pro secondary industry
Space Payloads & Instruments (Sensors, Comms, EO/IR) (IMABACAD)

Keywords

  • Microgravity research services
  • Space biomanufacturing
  • Cosmetic formulation testing
  • Bioactive compound development
  • Orbital laboratory services

Where SpacePharma is headquartered

Location

Headquarters

HQ city
Palo Alto
HQ country
United States
HQ region
North America

Markets served

SpacePharma business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Technology or R&D, Personnel, Infrastructure, Operations

Revenue model

  1. Co-innovation and Product Testing Services: SpacePharma provides microgravity testing and co-innovation services to cosmetic and personal care companies, enabling product development partnerships

Go-to-market motion1 record

Marketing channels1 record

SpacePharma product offering

Product offering

Core offering

SpacePharma provides end-to-end microgravity services and solutions for research, enabling cosmetic, biotechnology, and pharmaceutical companies to test products and develop novel formulations in orbital microgravity environments. The company conducts space-based experiments yielding bioactive compounds, radiation-protective ingredients, and antioxidant formulations for skin care applications, and operates an orbital laboratory platform that supports co-innovation and product testing partnerships.

Product overview

SpacePharma is a space biotechnology company offering microgravity-based research and product testing services. Their core offering revolves around providing access to orbital environments where cosmetic, pharmaceutical, and biotech products can be tested and developed under microgravity conditions. The company participates in industry conferences (such as IFSCC 2025 Congress) to discuss co-innovation opportunities with partners in the cosmetics and personal care industries.

Differentiator

Problem solved

Functional benefit

Products and services

  • Microgravity Research Services Laboratory services leveraging microgravity environments for product testing and co-innovation, particularly in the cosmetics and biotechnology sectors. Enables researchers to conduct experiments in orbital conditions that yield insights for skin care formulations and bioactive compound development, targeting cosmetics and personal care companies as well as biotech and pharma research organizations.

Companies that use SpacePharma

Customer profile

Segments1 record

Ideal customer profiles2 records

SpacePharma technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

SpacePharma partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • MEDEScoreStrategic or Co-development Partner · 19 September 2025MEDES (Institute for Space Medicine) and SpacePharma EU participated jointly in a round table discussion at IFSCC 2025 Congress exploring space research as a catalyst for cosmetic innovation. The partnership focuses on opportunities for co-innovation and product testing in microgravity environments, combining SpacePharma's microgravity expertise with MEDES' space medicine capabilities.

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

SpacePharma competitors and assessment

Company assessment

Direct peers

  • Rhodium Scientific: Operates a microgravity research services platform focused on biotech and life science experiments in low-Earth orbit, mirroring SpacePharma's end-to-end service model for biological and formulation research.
  • Yuri: Germany-based microgravity research services company providing access to ISS and suborbital platforms for life sciences and biotech R&D — a comparable European-headquartered peer serving similar customer profiles.
  • Space Tango: Provides microgravity research and manufacturing services aboard the ISS for biotech and consumer applications, with overlapping capabilities in formulation testing and space-grown bioactives — a direct head-to-head competitor.
  • Kayser Space: UK-based microgravity research services company providing payload development and experiment services to biotech and pharma clients, comparable in size and European market positioning.
  • Space Applications Services (ICE-Cubes): Operates the ICE-Cubes commercial service offering end-to-end access to the ISS for research payloads, with deep experience in biotech and pharma experiments analogous to SpacePharma's service scope.

Broad incumbents

  • Redwire Space: Established space infrastructure provider offering ISS payloads, biotech manufacturing facilities (e.g., BioFabrication Facility), and broader space services — competing in adjacent capabilities with significantly greater scale.
  • Voyager Space (formerly NanoRacks): Operates commercial ISS facilities and microgravity research services through the NanoRacks and Bishop Airlock franchises, serving as a larger-scale incumbent in commercial low-Earth-orbit R&D services.
  • Beyond Gravity (formerly RUAG Space): Major European space hardware and services supplier offering payload structures, mechanisms, and experiment support — adjacent competitor with broader scope and substantial industrial scale.
  • BioServe Space Technologies: University of Colorado-affiliated research center operating microgravity life-science experiments and payloads on ISS for academic and commercial clients — overlapping capability base with deeper scientific pedigree but academic rather than commercial-first orientation.

Emerging players

  • Angiex: Biotech company leveraging microgravity-based research for therapeutic antibody development; partial overlap with SpacePharma's space biotech platform but focused on oncology drug discovery rather than cosmetics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

SpacePharma social profiles

Digital presence

SpacePharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SpacePharma leadership team

Management profile

Number of profiles

Profiles2 records

SpacePharma funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SpacePharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SpacePharma

What does SpacePharma do?

SpacePharma provides end-to-end microgravity services and solutions for research, enabling cosmetic, biotechnology, and pharmaceutical companies to test products and develop novel formulations in orbital microgravity environments. The company conducts space-based experiments yielding bioactive compounds, radiation-protective ingredients, and antioxidant formulations for skin care applications, and operates an orbital laboratory platform that supports co-innovation and product testing partnerships.

Is SpacePharma a public or private company?

SpacePharma is a private company. It is classified as venture growth investor backed and is currently operating.

When was SpacePharma founded?

SpacePharma was founded in 2012. It employs 51 to 100 people.

Where is SpacePharma based?

SpacePharma is headquartered in Palo Alto, United States, in the North America region.

How does SpacePharma make money?

One revenue line is on record: co-innovation and Product Testing Services.

Who are SpacePharma's main competitors?

Direct peers on record are Rhodium Scientific, Yuri, Space Tango, Kayser Space and Space Applications Services (ICE-Cubes). Broad incumbents are Redwire Space, Voyager Space (formerly NanoRacks), Beyond Gravity (formerly RUAG Space) and BioServe Space Technologies. Angiex is listed as an emerging player.

Does SpacePharma have an API?

No public API is recorded for SpacePharma.

What industry is SpacePharma in?

SpacePharma's product category is Space Biotechnology Research Services. Its primary akta.pro industry code is HLAGAGAF, Analytical Development & QC Testing (Release/Stability/Potency), with a secondary code of IMABACAD, Space Payloads & Instruments (Sensors, Comms, EO/IR). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Cosmetics & ToiletriesCosmic Beauty: How Space Insights are Shaping Skin Care InnovationsResearch published in косметической науке explores how conditions aboard the International Space Station—including ionizing radiation, microgravity, and psychological stress—are accelerating skin aging processes in astronauts, providing a unique model for understanding environmental damage on Earth. косметична промисловість is applying these insights to develop new active ingredients and formulations, including antioxidants from radiation-resistant bacteria, space-cultivated plant stem cells, and self-assembling polymer delivery systems that function independently of gravity. Companies including Naples Soap Company, Delavie Sciences, and SpacePharma are actively commercializing space-derived cosmetic technologies, while microgravity-based research platforms are enabling more sensitive testing of ingredient efficacy.Cosmetics & ToiletriesHolistic Sciences: A Deep Dive into Day Two of the IFSCC 2025 CongressDay two of the IFSCC 2025 Congress focused on holistic sciences, featuring keynotes and sessions on skin microbiome, well-aging, and cellular longevity that explored integrated approaches to enhance cosmetic product performance. Researcher Marc-André Selosse highlighted how modern hygiene practices and cosmetic ingredients can damage skin microbiota, while Professor Jing Qu demonstrated plasma proteins' ability to predict biological age with approximately two years' accuracy using a multidimensional composite aging clock. A round table discussion explored space research as a catalyst for cosmetic innovation, with panelists from MEDES and SpacePharma EU discussing opportunities for co-innovation and product testing in microgravity environments.